SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.
Source: news-medical.net
Board Program At Harvard News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Board Program At Harvard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Board Program At Harvard Today - Breaking & Trending Today